Back to Agenda
Break-Out Room 1: Engage in small group discussions, address your challenges, and discover practical solutions
Session Chair(s)
Lauren East
Head, Pharmacovigilance UK
Abbvie, United Kingdom
Helen Fiddes
Head of Country Pharmacovigilance, UK and Ireland
Bristol-Myers Squibb, United Kingdom
Louise Woodward, PhD
UK QPPV and Local Safety Responsible
Roche Products Ltd, United Kingdom
Elspeth McIntosh, MBA, RN
Director
Castle Pharmacovigilance Ltd, United Kingdom
Participants will select one of the following interactive breakout rooms, where they can engage in focused discussions led by industry and MHRA representatives.
Speaker(s)
PSURs and RMP Break-Out Room
Lauren East
Abbvie, United Kingdom
Head, Pharmacovigilance UK
PSURs and RMP Break-Out Room
Emma Cornforth
Assessor MHRA, United Kingdom
Benefit Risk Assessor
PSURs and RMP Break-Out Room
Shazia Khalid
MHRA, United Kingdom
Scientific Assessor, Benefit Risk Evaluation Team II
Clinical Trial RSI Break-Out Room
Helen Fiddes
Bristol-Myers Squibb, United Kingdom
Head of Country Pharmacovigilance, UK and Ireland
Clinical Trial RSI Break-Out Room
Rachel Mead
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
GCP Inspector
Device Vigilance Break-Out Room
Louise Woodward, PhD
Roche Products Ltd, United Kingdom
UK QPPV and Local Safety Responsible
Device Vigilance Break-Out Room
James Whitehead, MBA, MSc
Visiting Lecturer - Pharmacovigilance MSc Course, University of Hertfordshire, United Kingdom
Former Senior Director Device & Digital Safety - AstraZeneca
Inspections Break-Out Room
Elspeth McIntosh, MBA, RN
Castle Pharmacovigilance Ltd, United Kingdom
Director
Inspections Break-Out Room
Sophie Radicke, MSc
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GPvP and Senior Pharmacovigilance Inspector
Inspections Break-Out Room
Claire Longman, MSc
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Expert Pharmacovigilance Inspector
Have an account?